stella
beta
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients — Stella
Home
/
FGF23-related Hypophosphataemic Rickets and Osteomalacia
/
View on ClinicalTrials.gov
Recruiting
Back to FGF23-related Hypophosphataemic Rickets and Osteomalacia trials
Trial locations
(13 sites)
South Korea
Wonju Severance Christian Hospital, Wŏnju, Gangwon-do
Ajou University Hospital, Suwon, Gyeonggi-do
Yangsan Pusan National University Hospital, Yangsan, Gyeongsangnam-do
Chonnam National University Hospital, Gwangju, Jeollanam-do
Chungnam National University Sejong Hospital, Sejong, Sejong Special Self-Governing City
Inje University Busan Paik Hospital, Busan
Pusan National University Hospital, Busan
Seoul National University Hospital, Seoul
Seoul National University Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Severance Hospital, Seoul
Korea University Guro Hospital, Seoul